Rare diseases
Investigational molecules
Locations
Back to Germany649 clinical trials in Langenau, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Nivolumab for Patients with Metastatic Solid Tumors and Leptomeningeal Disease
GermanyStudy of ivosidenib in adults with advanced or metastatic chondrosarcoma with IDH1 mutation who are untreated or have had one prior treatment
GermanyStudy to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer
GermanyComparison of belantamab mafodotin, bortezomib and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
GermanyStudy Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
GermanyStudy on Bortezomib for Patients with Severe Autoimmune Encephalitis
GermanyStudy on Nipocalimab for Adults with Generalized Myasthenia Gravis
GermanyStudy on the Effects of Iptacopan in Patients with Idiopathic Membranoproliferative Glomerulonephritis (IC-MPGN)
GermanyStudy on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures
GermanyStudy on the Effects of Metreleptin for Patients with Partial Lipodystrophy
GermanyStudy on Aconite Pain Oil to Prevent and Reduce Symptoms of Chemotherapy-Induced Polyneuropathy in Cancer Patients
GermanyStudy on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on plaque psoriasis and psoriatic arthritis, evaluating novel therapeutic approaches for both biologic-naive and experienced patients. Studies aim to assess treatment efficacy in reducing disease symptoms and improving patient outcomes.
Multiple investigations are comparing new therapeutic agents against placebo and established treatments.
Comprehensive studies addressing hidradenitis suppurativa and atopic dermatitis. Research focuses on evaluating new treatments for these challenging conditions, with emphasis on both immediate efficacy and long-term management.
Trials are examining both topical and systemic treatments for optimal disease control.
Innovative research addressing various skin conditions including chronic venous ulcers, actinic keratosis, and rosacea. Studies range from stem cell therapies for wound healing to novel topical treatments.
Research includes both traditional and cutting-edge therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
